Hyun Park MD, PhD, FACAAI, FACP

Education

PhD - University of Texas M. D. Anderson Cancer Center
MD - Texas Tech University Health Science Center - El Paso
BSI - Baylor University

Representative Bibliography

1. S.M. Kodoth, N.C. Patel, H.J. Park, J.P. Brooks. In-flight Epinephrine Access during Allergic Emergencies: The Allergists' Experience. Annals of Allergy, Asthma, & Immunology, October 2025. PMID: 40651562

2. H.J. Park, K.C. Alcover, Q. Wang, S.M. Gada. SARS-CoV-2 Antibody Longitudinal Profile of Immune Globulin Preparations. Military Medicine, June 29, 2022. PMID: 35769049

3. H.J. Park, N.L. Watson, R.H. Wauters, E.M. Lomasney, C.P. Punch, V.A. Dewyea, M.O. Evans, C.S. Chavarria, S.C. Wong, C.J. Calais, M.R. Kaplan, T.A. Banks, D.E. Beakes, D.J. Schwartz. Multisite evaluation of fire ant venom immunotherapy safety and efficacy. The Journal of Allergy and Clinical Immunology: Global, April 15, 2022. PMID: 37781270

4. A.M. Waters, H.J. Park, A.L. Weskamp, A. Mateja, M.E. Kachur, J.J. Lyons, B.J. Rosen, N.A. Boggs. Elevated basal serum tryptase: disease distribution and variability in a regional health system. The Journal of Allergy and Clinical Immunology: In Practice, January 12, 2022. PMID: 35032694

5. H.J. Park, D.I. Brooks, C.S. Chavarria, R.L. Wu, C.P. Mikita, D.E. Beakes. Combining Discordant Serum IgE and Skin Testing Improves Diagnostic and Therapeutic Accuracy for Hymenoptera Venom Hypersensitivity Immunotherapy. The Journal of Allergy and Clinical Immunology: In Practice, September 14, 2021. PMID:34534718

6. H.J. Park, J.R. Montgomery, N.A. Boggs. Anaphylaxis After the Covid-19 Vaccine in a Patient with Cholinergic Urticaria. Military Medicine, April 14, 2021. PMID:33851711

7. S. Rawal, F. Chu, M. Zhang, H.J. Park, D. Nattamai, S. Kannan, R. Sharma, D. Delgado, T. Chou, H.Y. Lin, V. Baladandayuthapani, A. Luong, F. Vega, N. Fowler, C. Dong, R.E. Davis, S.S. Neelapu. Cross Talk between Follicular Th Cells and Tumor Cells in Human Follicular Lymphoma Promotes Immune Evasion in the Tumor Microenvironment. Journal of Immunology, May 17, 2013. PMID:23686488

8. J. Weng, S. Rawal, F. Chu, H.J. Park, R. Sharma, D.A. Delgado, L. Fayad, M. Fanale, J. Romaguera, A. Luong, L.W. Kwak, S.S. Neelapu. TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas. Blood, May 29, 2012. PMID:22645177

9. H.J. Park, H. Qin, S.C. Cha, R. Sharma, Y. Chung, K.S. Schluns, S.S. Neelapu, W.W. Overwijk, P. Hwu, L.W. Kwak. Induction of TLR4-dependent CD8+ T cell immunity by murine beta-defensin2 fusion protein vaccines. Vaccine, 29:3476-3482, April 18, 2011. PMID:21382485

10. H.J. Park, S.S. Neelapu. Developing idiotype vaccines for lymphoma: From preclinical studies to Phase III clinical trials. British Journal of Haematology, 142:179-191, June, 2008. PMID:18422783